Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.58 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.56 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | DPP4 | P27487 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | SRC | P12931 | 1/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16816913 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL17982719 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL10535250 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL8229978 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL751652 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL4728748 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL210030 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL8528068 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| SCHEMBL443815 | 1.00 | LMNA (0.58) | LMNANR1I2PTGS1ADRA1ABLM | |
| Hydrochloric Acid SCHEMBL6946154 | 0.98 | ALDH1A1 (0.57) | LMNANR1I2PTGS1ADRA1ABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| WO-2024190663-A1 | BIOMARKER AND USE THEREOF | 株式会社明治 | 2024-09-19 | — | — | WO | claimed |
| US-4710583-A | ENZYMATIC COUPLING OF PHENYLSERINE WITH ASPARTIC ACID; HYDROGENATION | W. R. GRACE & CO. (US) | 1987-12-01 | — | — | US | claimed |
| US-4668796-A | Racemates of optically active bicyclic imino-alpha-carboxylic esters | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-05-26 | — | — | US | claimed |
| US-20230410977-A1 | METHODS AND MATERIALS FOR ASSESSING RADIATION EXPOSURE | NUTECH VENTURES | 2023-12-21 | — | — | US | disclosed |
| WO-2022140565-A1 | METHODS AND MATERIALS FOR ASSESSING RADIATION EXPOSURE | NUTECH VENTURES (US) | 2022-06-30 | — | — | WO | disclosed |
| EP-3916003-A1 | N-METHYL-D-ASPARTATE RECEPTOR MODULATORS AND METHODS OF MAKING AND USING SAME | Naurex, Inc. (US) | 2021-12-01 | — | — | EP | disclosed |
| EP-3171941-B1 | N-METHYL-D-ASPARTATE RECEPTOR MODULATORS AND METHODS OF MAKING AND USING SAME | NAUREX INC (US) | 2021-03-24 | — | — | EP | disclosed |
| US-9994614-B2 | N-methyl-D-aspartate receptor modulators and methods of making and using same | NAUREX, INC. (US) | 2018-06-12 | — | — | US | disclosed |
| US-20170210779-A1 | N-METHYL-D-ASPARTATE RECEPTOR MODULATORS AND METHODS OF MAKING AND USING SAME | NAUREX INC (US) | 2017-07-27 | — | — | US | disclosed |
| EP-2353714-A1 | ASYMMETRIC HYDROGENATION CATALYST | Takasago International Corporation (JP) | 2011-08-10 | — | — | EP | disclosed |
| US-7572607-B2 | Polypeptides and biosynthetic pathways for the production of monatin and its precursors | CARGILL, INCORPORATED (US) | 2009-08-11 | — | — | US | disclosed |
| US-6277416-B1 | CARRIER SYSTEM HAVING AT LEAST ONE WETTING AGENT AND HAVING AT LEAST ONE PENETRATION AGENT, WHEREIN SAID SOLUTION IS ABSORBED INTO THE DISEASED PLANT. | CAMAS TECHNOLOGIES, INC. | 2001-08-21 | — | — | US | disclosed |
| EP-0920336-A1 | PESTICIDES COMPRISING BENZOPHENANTHRIDINE ALKALOIDS | Camas Technologies, Inc. (US) | 1999-06-09 | — | — | EP | disclosed |
| US-5789599-A | Aziridine compounds, methods of preparation and reactions thereof | DREXEL UNIVERSITY (US) | 1998-08-04 | — | — | US | disclosed |
| WO-1997041890-A1 | PESTICIDES COMPRISING BENZOPHENANTHRIDINE ALKALOIDS | CAMAS TECHNOLOGIES, INC. (US) | 1997-11-13 | — | — | WO | disclosed |
| US-5128478-A | From aldehyde and isocyanato carboxylate | AJINOMOTO CO., INC. (JP) | 1992-07-07 | — | — | US | disclosed |
| US-4873359-A | Process for preparing as partyl-phenylalanine dipeptides | W. R. GRACE & CO. - CONN. (US) | 1989-10-10 | — | — | US | disclosed |
| US-4810817-A | ARTIFICIAL SWEETENERS | W. R. GRACE & CO. (US) | 1989-03-07 | — | — | US | disclosed |
| US-4710583-A | ENZYMATIC COUPLING OF PHENYLSERINE WITH ASPARTIC ACID; HYDROGENATION | W. R. GRACE & CO. (US) | 1987-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170210779-A1 | N-METHYL-D-ASPARTATE RECEPTOR MODULATORS AND METHODS OF MAKING AND USING SAME | GRIN1, GRIN2A, GRIN3A | LMNA 4777/4885NR1I2 537/4885PTGS1 613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.